GE MEDICAL SYSTEMS

๐Ÿ‡ซ๐Ÿ‡ทFrance
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Orthopedic Knee Measurement Using Lunar iDXA

First Posted Date
2011-05-06
Last Posted Date
2017-06-22
Lead Sponsor
GE Healthcare
Target Recruit Count
36
Registration Number
NCT01348958
Locations
๐Ÿ‡ณ๐Ÿ‡ฟ

CGM Research Trust - Princess Margaret Hospital, Cashmere, Christchurch, New Zealand

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2011-02-24
Last Posted Date
2019-04-10
Lead Sponsor
GE Healthcare
Target Recruit Count
224
Registration Number
NCT01303419
Locations
๐Ÿ‡ง๐Ÿ‡ช

AZ St-Jan Brugge AV, Brugge, Belgium

๐Ÿ‡บ๐Ÿ‡ธ

Seattle Cancer Care Alliance, Seattle, Washington, United States

๐Ÿ‡ฉ๐Ÿ‡ช

Institut fur Radiologie, Charite, Berlin, Germany

and more 2 locations

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-12-23
Last Posted Date
2013-07-02
Lead Sponsor
GE Healthcare
Target Recruit Count
218
Registration Number
NCT01265394
Locations
๐Ÿ‡บ๐Ÿ‡ธ

GE Healthcare, Princeton, New Jersey, United States

Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

First Posted Date
2010-12-03
Last Posted Date
2018-08-29
Lead Sponsor
GE Healthcare
Target Recruit Count
284
Registration Number
NCT01252810
Locations
๐Ÿ‡บ๐Ÿ‡ธ

GE Healthcare, Princeton, New Jersey, United States

NICU-TECH RM9L-RS Probe ME Feasibility Study

Terminated
Conditions
First Posted Date
2010-08-13
Last Posted Date
2019-08-06
Lead Sponsor
GE Healthcare
Target Recruit Count
31
Registration Number
NCT01181596
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSD Medical Center, San Diego, California, United States

GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2010-08-06
Last Posted Date
2014-02-14
Lead Sponsor
GE Healthcare
Target Recruit Count
25
Registration Number
NCT01176513
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-07-20
Last Posted Date
2013-12-04
Lead Sponsor
GE Healthcare
Target Recruit Count
203
Registration Number
NCT01165554
Locations
๐Ÿ‡บ๐Ÿ‡ธ

GE Healthcare, Princeton, New Jersey, United States

Technical Validation of Lunar iDXA Visceral Fat Tool

Completed
Conditions
Interventions
First Posted Date
2010-04-26
Last Posted Date
2010-12-08
Lead Sponsor
GE Healthcare
Target Recruit Count
148
Registration Number
NCT01110161
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Fudan University Zhongshan Hospital, Shanghai, China

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2010-03-25
Last Posted Date
2013-12-13
Lead Sponsor
GE Healthcare
Target Recruit Count
12
Registration Number
NCT01092546
Locations
๐Ÿ‡บ๐Ÿ‡ธ

GE Healthcare, Princeton, New Jersey, United States

A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System

First Posted Date
2010-02-26
Last Posted Date
2016-03-07
Lead Sponsor
GE Healthcare
Target Recruit Count
1000
Registration Number
NCT01076296
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health & Science University, Portland, Oregon, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath